1eba

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
(New page: 200px<br /> <applet load="1eba" size="450" color="white" frame="true" align="right" spinBox="true" caption="1eba, resolution 2.7&Aring;" /> '''COMPLEX BETWEEN THE ...)
Line 1: Line 1:
-
[[Image:1eba.gif|left|200px]]<br />
+
[[Image:1eba.gif|left|200px]]<br /><applet load="1eba" size="350" color="white" frame="true" align="right" spinBox="true"
-
<applet load="1eba" size="450" color="white" frame="true" align="right" spinBox="true"
+
caption="1eba, resolution 2.7&Aring;" />
caption="1eba, resolution 2.7&Aring;" />
'''COMPLEX BETWEEN THE EXTRACELLULAR DOMAIN OF ERYTHROPOIETIN (EPO) RECEPTOR [EBP] AND AN INACTIVE PEPTIDE [EMP33] CONTAINS 3,5-DIBROMOTYROSINE IN POSITION 4 (DENOTED DBY)'''<br />
'''COMPLEX BETWEEN THE EXTRACELLULAR DOMAIN OF ERYTHROPOIETIN (EPO) RECEPTOR [EBP] AND AN INACTIVE PEPTIDE [EMP33] CONTAINS 3,5-DIBROMOTYROSINE IN POSITION 4 (DENOTED DBY)'''<br />
==Overview==
==Overview==
-
Dimerization of the erythropoietin (EPO) receptor (EPOR), in the presence, of either natural (EPO) or synthetic (EPO-mimetic peptides, EMPs) ligands, is the principal extracellular event that leads to receptor activation., The crystal structure of the extracellular domain of EPOR bound to an, inactive (antagonist) peptide at 2.7 A resolution has unexpectedly, revealed that dimerization still occurs, but the orientation between, receptor molecules is altered relative to active (agonist) peptide, complexes. Comparison of the biological properties of agonist and, antagonist EMPs with EPO suggests that the extracellular domain, orientation is tightly coupled to the cytoplasmic signaling events and, hence, provides valuable new insights into the design of synthetic ligands, for EPOR and other cytokine receptors.
+
Dimerization of the erythropoietin (EPO) receptor (EPOR), in the presence of either natural (EPO) or synthetic (EPO-mimetic peptides, EMPs) ligands is the principal extracellular event that leads to receptor activation. The crystal structure of the extracellular domain of EPOR bound to an inactive (antagonist) peptide at 2.7 A resolution has unexpectedly revealed that dimerization still occurs, but the orientation between receptor molecules is altered relative to active (agonist) peptide complexes. Comparison of the biological properties of agonist and antagonist EMPs with EPO suggests that the extracellular domain orientation is tightly coupled to the cytoplasmic signaling events and, hence, provides valuable new insights into the design of synthetic ligands for EPOR and other cytokine receptors.
==Disease==
==Disease==
Line 11: Line 10:
==About this Structure==
==About this Structure==
-
1EBA is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=1EBA OCA].
+
1EBA is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1EBA OCA].
==Reference==
==Reference==
Line 18: Line 17:
[[Category: Single protein]]
[[Category: Single protein]]
[[Category: Livnah, O.]]
[[Category: Livnah, O.]]
-
[[Category: Stura, E.A.]]
+
[[Category: Stura, E A.]]
-
[[Category: Wilson, I.A.]]
+
[[Category: Wilson, I A.]]
[[Category: complex (cytokine receptor/peptide)]]
[[Category: complex (cytokine receptor/peptide)]]
[[Category: cytokine receptor class 1]]
[[Category: cytokine receptor class 1]]
Line 27: Line 26:
[[Category: signal transduction]]
[[Category: signal transduction]]
-
''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Mon Nov 12 16:41:54 2007''
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 12:25:59 2008''

Revision as of 10:26, 21 February 2008


1eba, resolution 2.7Å

Drag the structure with the mouse to rotate

COMPLEX BETWEEN THE EXTRACELLULAR DOMAIN OF ERYTHROPOIETIN (EPO) RECEPTOR [EBP] AND AN INACTIVE PEPTIDE [EMP33] CONTAINS 3,5-DIBROMOTYROSINE IN POSITION 4 (DENOTED DBY)

Contents

Overview

Dimerization of the erythropoietin (EPO) receptor (EPOR), in the presence of either natural (EPO) or synthetic (EPO-mimetic peptides, EMPs) ligands is the principal extracellular event that leads to receptor activation. The crystal structure of the extracellular domain of EPOR bound to an inactive (antagonist) peptide at 2.7 A resolution has unexpectedly revealed that dimerization still occurs, but the orientation between receptor molecules is altered relative to active (agonist) peptide complexes. Comparison of the biological properties of agonist and antagonist EMPs with EPO suggests that the extracellular domain orientation is tightly coupled to the cytoplasmic signaling events and, hence, provides valuable new insights into the design of synthetic ligands for EPOR and other cytokine receptors.

Disease

Known disease associated with this structure: Erythrocytosis, familial OMIM:[133171]

About this Structure

1EBA is a Single protein structure of sequence from Homo sapiens. Full crystallographic information is available from OCA.

Reference

An antagonist peptide-EPO receptor complex suggests that receptor dimerization is not sufficient for activation., Livnah O, Johnson DL, Stura EA, Farrell FX, Barbone FP, You Y, Liu KD, Goldsmith MA, He W, Krause CD, Pestka S, Jolliffe LK, Wilson IA, Nat Struct Biol. 1998 Nov;5(11):993-1004. PMID:9808045

Page seeded by OCA on Thu Feb 21 12:25:59 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools